GO

> Technology > Intellectual Property

RNLBIO is a leading biopharmaceutical company dedicated in developing stem cell therapeutics for treating cellular damage disease and offeres an integrated services in adult stem cell banking, research and therpy.

• A method for culturing and proliferating hematopoietic stem cell and progenitor cell by using human endometrial cells
• Multipotent Stem Cell Derived from Human Adipose Tissue and Cellular Therapeutic Agents Comprising the Same
• Multipotent Adult Stem Cells Having an Ability of Oct4 Expression Derived from umbilical cord blood and Method for Preparing the Same
• Multipotent stem cells isolated from umbilical cord blood and the cellular therapeutic agent comprising the same for treating ischemic disease
• Pharmaceutical composign comprising p38 MAP kinase inhibitor for treating diseases caused by NPC1 gene deficiency or self-renewal disorder of stem cells
• NPC1 Gene Concerned in Self-renewal and Differentiation of Neural Stem Cells and Use Thereof
• Multipotent Stem Cell Derived from Placenta Tissue and Cellular Therapeutic Agents Comprising the Same
• Method for Prepating Cosmetic or Plastic Composition for Skin Comprising Adipocyte, Fibroblast and Multipotent Stem cell Derived from Human Adipose Tissue
• Cosmetic or plastic composition comprising multipotent stem cells dericed from human adipose tissue, fibroblast and adipose or adipocyte
• A method for culturing amnion based epithelial stem cells and epithelial stem cells as wound treatmentent obtained from this method
• Method for Culturing and Proliferating of Hematopoietic Cells Through Co-culture with Adult Stem Cells
• Hair reproducing stimulant using autologous hair follicular cells and composition thereof
• Pharmaceutical composition for preventing and treating liver fibrosis or hepatic cirrhosis comprising mesenchymal stem cell
• Composition for Treating of Ischemic Limb Disease comprising Stem Cells Derived from Adipose Tissue
• METHOD FOR PREPARING T CELL PROGENITOR FROM CD34 POSITIVE STEM CELL
• Method for Isolating and Culturing Adult Stem Cells Derived from Human Amniotic Epithelium
• Celluar Therapeutic Agent for Incontinence of Urine Comprising Stem Cells originated from Decidua or Adipose
• Cosmetic composition Comprising Matrials cultured Multipotent Stem Cells Derived from Humam Adipose Tissue and Proteins extracte therefrom
• Cosmetic Composition Comprising Matrials cultured Adult Stem Cells Derived from Swine Placenta Tissue and Proteins extracted therefrom
• Composition Comprising Derived Placenta-Drived Stem Cells for Treating a Burn Wound
• Method for Preparing Induced Pluripotent Stem Cells
• Anticancer Compound containing Human-derived Adult Stem Cells
• Method for inducing Movement of Adipose-derived Adult Stem Cells
• Method for Mass Propagation of Hair Follicle Stem Cells
• System and Method for providing Custom Cosmetics containing Stem Cells
• Method for inducing Movement of Adipose-derived Adult Stem Cells
• Compound for enhancing Stem Cell Safety